Niva Bupa Health Insurance Company Limited has successfully concluded its postal ballot process, with shareholders overwhelmingly approving two critical resolutions through remote e-voting. The voting process concluded on March 26, 2026, at 05:00 P.M., marking a significant milestone in the company's governance activities.

Approved Resolutions

Shareholders approved two ordinary resolutions with remarkable consensus. The voting results demonstrate strong shareholder confidence in the company's strategic decisions and leadership structure.

Voting Results and Participation

The postal ballot process was conducted entirely through remote e-voting, facilitated by KFin Technologies Limited. The voting period commenced on February 25, 2026, at 09:00 A.M. and concluded on March 26, 2026, at 05:00 P.M.

Resolution 1: Director Appointment

The appointment of Mr. Roger William John Davis as Non-Executive Director received exceptional support from shareholders.

Resolution 2: CEO Remuneration Revision

The revision in remuneration for Managing Director & CEO Mr. Krishnan Ramachandran also secured overwhelming approval.

Process and Compliance

The postal ballot process was conducted in strict compliance with regulatory requirements. CS Ranjeet Pandey of M/s Ranjeet Pandey & Associates served as the Scrutinizer, ensuring transparency and fairness throughout the voting process. The cut-off date for determining eligible shareholders was February 20, 2026.

The company dispatched the postal ballot notice dated February 19, 2026, to eligible shareholders on February 23, 2026, through electronic means only. Additionally, the company published advertisements in Business Standard on February 24, 2026, informing shareholders about the completion of notice dispatch.

Regulatory Compliance

The postal ballot was conducted pursuant to Sections 108 and 110 of the Companies Act, 2013, read with Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014. The process also complied with SEBI Listing Regulations and relevant MCA circulars, including General Circular No. 03/2025 dated September 22, 2025.

The successful completion of this postal ballot process reinforces shareholder confidence in the company's governance practices and strategic direction. Both resolutions receiving near-unanimous approval reflects strong stakeholder alignment with the company's leadership decisions and compensation policies.

Niva bupa health insurance company Limited has announced its participation in an investor interaction organized by ICICI Securities, scheduled for March 30, 2026. The company informed both the National Stock Exchange of India Limited and BSE Limited about this engagement through a regulatory filing dated March 24, 2026.

Meeting Details

The investor interaction is structured as a group meeting and will take place at Grand Hyatt, Santacruz, Mumbai. Company representatives will participate in this engagement to interact with analysts and investors.

Regulatory Compliance

The company has emphasized its commitment to regulatory compliance by stating that no unpublished price sensitive information will be shared during the meeting. This disclosure was made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Important Considerations

Niva Bupa Health Insurance Company Limited has noted that the meeting schedule is subject to potential changes due to exigencies that may arise from the part of analysts, investors, or the company itself. This flexibility clause ensures that all parties can accommodate any unforeseen circumstances that might affect the scheduled interaction.

The communication was signed by Aparna Sharma, Company Secretary and Compliance Officer, and was digitally authenticated on March 24, 2026, at 17:52:45 +05'30'.